These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 22877564)

  • 1. Exhaled matrix metalloproteinase-9 in lung cancer.
    Carpagnano GE; Palladino GP; Martinelli D; Lacedonia D; Orlando S; Foschino-Barbaro MP
    Rejuvenation Res; 2012 Aug; 15(4):359-65. PubMed ID: 22877564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased levels of exhaled sICAM1, sVCAM1, and sE-selectin in patients with non-small cell lung cancer.
    Zhou F; Chen J; Tao G; Zhu M; Xie W; Cao X
    Respir Med; 2014 Nov; 108(11):1670-6. PubMed ID: 25179787
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 3p microsatellite alterations in exhaled breath condensate from patients with non-small cell lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Mulé G; Resta O; Tommasi S; Mangia A; Carpagnano F; Stea G; Susca A; Di Gioia G; De Lena M; Paradiso A
    Am J Respir Crit Care Med; 2005 Sep; 172(6):738-44. PubMed ID: 15947287
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced exhalation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteinase-1 in patients with COPD exacerbation: a prospective study.
    Kwiatkowska S; Noweta K; Zieba M; Nowak D; Bialasiewicz P
    Respiration; 2012; 84(3):231-41. PubMed ID: 22832426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cigarette smoke and increased COX-2 and survivin levels in exhaled breath condensate of lung cancer patients: how hot is the link?
    Carpagnano GE; Spanevello A; Palladino GP; Gramiccioni C; Ruggieri C; Carpagnano F; Foschino Barbaro MP
    Lung Cancer; 2010 Jan; 67(1):108-13. PubMed ID: 19423183
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Methylation of P16 in exhaled breath condensate for diagnosis of non-small cell lung cancer.
    Xiao P; Chen JR; Zhou F; Lu CX; Yang Q; Tao GH; Tao YJ; Chen JL
    Lung Cancer; 2014 Jan; 83(1):56-60. PubMed ID: 24268095
    [TBL] [Abstract][Full Text] [Related]  

  • 7. 3p microsatellite signature in exhaled breath condensate and tumor tissue of patients with lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Spanevello A; Resta O; Carpagnano F; Mulé G; Pinto R; Tommasi S; Paradiso A
    Am J Respir Crit Care Med; 2008 Feb; 177(3):337-41. PubMed ID: 17962633
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic value of exhaled microsatellite alterations at 3p in NSCLC patients.
    Carpagnano GE; Spanevello A; Carpagnano F; Palladino GP; Prato R; Martinelli D; Digioia G; Foschino-Barbaro MP
    Lung Cancer; 2009 Jun; 64(3):334-40. PubMed ID: 18995925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exhaled ERCC-1 and ERCC-2 microsatellite alterations in NSCLC patients.
    Carpagnano GE; Palladino GP; Gramiccioni C; Foschino Barbaro MP; Martinelli D
    Lung Cancer; 2010 May; 68(2):305-7. PubMed ID: 20188432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CEA, SCC and NSE levels in exhaled breath condensate--possible markers for early detection of lung cancer.
    Zou Y; Wang L; Zhao C; Hu Y; Xu S; Ying K; Wang P; Chen X
    J Breath Res; 2013 Dec; 7(4):047101. PubMed ID: 24185583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endothelin-1 is increased in the breath condensate of patients with non-small-cell lung cancer.
    Carpagnano GE; Foschino-Barbaro MP; Resta O; Gramiccioni E; Carpagnano F
    Oncology; 2004; 66(3):180-4. PubMed ID: 15218307
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inflammatory cytokines and VEGF measured in exhaled breath condensate are correlated with tumor mass in non-small cell lung cancer.
    Brussino L; Culla B; Bucca C; Giobbe R; Boita M; Isaia G; Heffler E; Oliaro A; Filosso P; Rolla G
    J Breath Res; 2014 Jun; 8(2):027110. PubMed ID: 24861949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression and clinical significance of matrix metalloproteinase (MMP)-26 protein in non-small cell lung cancer.
    Li L; Mei TH; Zhou XD; Zhang XG
    Ai Zheng; 2009 Jan; 28(1):60-3. PubMed ID: 19448419
    [TBL] [Abstract][Full Text] [Related]  

  • 14. VEGF, TNF-alpha and 8-isoprostane levels in exhaled breath condensate and serum of patients with lung cancer.
    Dalaveris E; Kerenidi T; Katsabeki-Katsafli A; Kiropoulos T; Tanou K; Gourgoulianis KI; Kostikas K
    Lung Cancer; 2009 May; 64(2):219-25. PubMed ID: 18845357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase-9 in broncho-alveolar lavage fluid of patients with non-small cell lung cancer.
    Bugdayci G; Kaplan T; Sezer S; Turhan T; Koca Y; Kocer B; Yildirim E
    Exp Oncol; 2006 Jun; 28(2):169-71. PubMed ID: 16837913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Exhaled HPV infection in lung cancer: role of MA at 3p.
    Carpagnano GE; Lacedonia D; Crisetti E; Palladino GP; Saliani V; Zoppo LD; Antonetti R; Natalicchio I; Foschino-Barbaro MP
    Arch Med Res; 2014 Jul; 45(5):383-7. PubMed ID: 24962429
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exhaled breath condensate MMP-9 level and its relationship wıth asthma severity and interleukin-4/10 levels in children.
    Karakoc GB; Yukselen A; Yilmaz M; Altintas DU; Kendirli SG
    Ann Allergy Asthma Immunol; 2012 May; 108(5):300-4. PubMed ID: 22541398
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Progression of non-small cell lung cancer: diagnostic and prognostic utility of matrix metalloproteinase-2, C-reactive protein and serum amyloid A.
    Kanoh Y; Abe T; Masuda N; Akahoshi T
    Oncol Rep; 2013 Feb; 29(2):469-73. PubMed ID: 23135313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matrix metalloproteinase-9 expression in lung cancer patients and its relation to serum mmp-9 activity, pathologic type, and prognosis.
    El-Badrawy MK; Yousef AM; Shaalan D; Elsamanoudy AZ
    J Bronchology Interv Pulmonol; 2014 Oct; 21(4):327-34. PubMed ID: 25321452
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum matrix metalloproteinases -2, -9 and tissue inhibitors of metalloproteinases -1, -2 in lung cancer--TIMP-1 as a prognostic marker.
    Ylisirniö S; Höyhtyä M; Turpeenniemi-Hujanen T
    Anticancer Res; 2000; 20(2B):1311-6. PubMed ID: 10810441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.